We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 434

New challenges and opportunities for pharmaceutical trademarks in Canada
  • Smart & Biggar/Fetherstonhaugh
  • Canada
  • October 2 2017

In Canada, trademarks for pharmaceutical preparations and related products have faced numerous challenges, some of which are unique to the industry

Germany: Counterfeiting, 3D printing and the third Industrial Revolution
  • Meissner Bolte
  • Germany
  • January 1 2017

The opportunities presented by three-dimensional (3D) printing have been widely discussed and acknowledged. It is commonly predicted that 3D printing

TTAB Test: Are HOLAIRA and ALAIR Confusable for Lung-Related Medical Devices?
  • Wolf, Greenfield & Sacks, PC
  • USA
  • November 17 2016

Boston Scientific opposed an application to register the mark HOLAIRA for "medical devices for treating obstructive lung diseases; medical apparatus

FDA reports results of annual crack down on illegal internet pharmacies
  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • USA
  • June 26 2015

Last week, FDA announced that more than 1,050 websites had illegal drugs and devices seized or received warning letters as part of the Eighth Annual

EU Court finds pharmaceutical products similar to surgical devices in likely confusion test
  • FRKelly
  • European Union
  • January 29 2015

On September 10th 2014, the General Court ruled that there is a certain degree of similarity between goods in class 5; pharmaceutical products, and

Parallel importation of medical devices: necessary repackaging vs “opportunistic” repackaging
  • Martini Manna Avvocati
  • Italy
  • July 8 2014

A permanent legal conflict is ongoing in the European Union between manufacturers and parallel importers of medical devices, in which single battles

  • Germany
  • September 17 2013

On the regulatory side, the Federal Institute for Drugs and Medical Devices is the authority competent to grant a national marketing authorisation for

Farmacovigilancia: restringida la venta a domicilio y la venta indirecta de los productos sanitarios, los cosméticos y los de cuidado personal
  • Abril Abogados
  • Spain, European Union
  • September 14 2013

Recientemente ha entrado en vigor de la Ley 102013 de 24 de Julio, por la que se incorporan las Directivas 201084UE del Parlamento Europeo y

3D shape mark held to be indistinctive
  • Wilkinson & Grist
  • Hong Kong
  • April 3 2013

An application to register the three-dimensional (3D) shape mark shown below for medical devices in Class 10 has been refused for being devoid of

Pharmaceutical brand owners beware changes to medicine packaging ahead
  • Norton Rose Fulbright Australia
  • Australia
  • November 30 2012

In the coming year the TGA will aim to change the way pharmaceuticals can be labelled to restrict some brand extensions